Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2

Free Radical Biology and Medicine

Volumn 89, Issue , 2015, Pages 358-368

  Ramkissoon, Annmarie ^a   Wells, Peter G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Behavioral abnormalities; DNA oxidation; Free radicals; Methamphetamine; Neurodegeneration; Nrf2; Reactive oxygen species

Indexed keywords

DNA; DOPAMINE TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TYROSINE 3 MONOOXYGENASE; CENTRAL STIMULANT AGENT; DOPAMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DNA METABOLISM; DNA OXIDATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; FUNCTIONAL DISEASE; GABAERGIC SYSTEM; GLIA CELL; HISTOPATHOLOGY; HYPERTHERMIA; MALE; METABOLISM; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NISSL STAINING; NONHUMAN; OLFACTORY BULB; OLFACTORY DISCRIMINATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; SMELLING DISORDER; TRANSCRIPTION INITIATION; ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENZYME IMMUNOASSAY; FEVER; GENETICS; HUMAN; KNOCKOUT MOUSE; NEUROTOXICITY SYNDROMES; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; FEVER; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; NEUROTOXICITY SYNDROMES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 84943395160     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.07.157     Document Type: Article

References (36)

1. H. Kalant The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs CMAJ 165 2001 917 928
2. N. Granado, I. Lastres-Becker, S. Ares-Santos, I. Oliva, E. Martin, A. Cuadrado, and R. Moratalla Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum Glia 59 2011 1850 1863
3. X. Deng, B. Ladenheim, S. Jayanthi, and J.L. Cadet Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb Biol. Psychiatry 61 2007 1235 1243
4. W. Jeng, A. Ramkissoon, T. Parman, and P.G. Wells Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration FASEB J 20 2006 638 650
5. S. Jayanthi, B. Ladenheim, and J.L. Cadet Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice Ann. N. Y. Acad. Sci. 844 1998 92 102
6. P.G. Wells, G.P. McCallum, C.S. Chen, J.T. Henderson, C.J. Lee, J. Perstin, T.J. Preston, M.J. Wiley, and A.W. Wong Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer Toxicol. Sci. 108 2009 4 18
7. N.C. Burton, T.W. Kensler, and T.R. Guilarte In vivo modulation of the Parkinsonian phenotype by Nrf2 Neurotoxicology 27 2006 1094 1100
8. M.J. Calkins, R.J. Jakel, D.A. Johnson, K. Chan, Y.W. Kan, and J.A. Johnson Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription Proc. Natl. Acad. Sci. USA 102 2005 244 249
9. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86
10. A. Dhenaut, S. Hollenbach, I. Eckert, B. Epe, S. Boiteux, and J.P. Radicella Characterization of hOGG1 promoter structure, expression during cell cycle and overexpression in mammalian cells Adv. Exp. Med. Biol. 500 2001 613 616
11. J.M. Lee, M.J. Calkins, K. Chan, Y.W. Kan, and J.A. Johnson Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis J. Biol. Chem. 278 2003 12029 12038
12. B. Singh, A. Chatterjee, A.M. Ronghe, N.K. Bhat, and H.K. Bhat Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer BMC Cancer 13 2013 253
13. A.W. Wong, G.P. McCallum, W. Jeng, and P.G. Wells Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits J. Neurosci. 28 2008 9047 9054
14. A.M. Pacchioni, J. Vallone, R.I. Melendez, A. Shih, T.H. Murphy, and P.W. Kalivas Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity Brain. Res. 1127 2007 26 35
15. S. Jayanthi, M.T. McCoy, G. Beauvais, B. Ladenheim, K. Gilmore, W. Wood 3rd, K. Becker, and J.L. Cadet Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum PLoS One 4 2009 e6092
16. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
17. J.P. O'Callaghan, and D.B. Miller Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse J. Pharmacol. Exp. Ther. 270 1994 741 751
18. A.K. Cho, W.P. Melega, R. Kuczenski, and D.S. Segal Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse Synapse 39 2001 161 166
19. J.L. Ravanat, T. Douki, P. Duez, E. Gremaud, K. Herbert, T. Hofer, L. Lasserre, C. Saint-Pierre, A. Favier, and J. Cadet Cellular background level of 8-oxo-7,8-dihydro-2′-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up Carcinogenesis 23 2002 1911 1918
20. L.L. Goncalves, A. Ramkissoon, and P.G. Wells Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies Chem. Res. Toxicol. 22 2009 842 852
21. J.L. Tillerson, W.M. Caudle, J.M. Parent, C. Gong, T. Schallert, and G.W. Miller Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor Behav. Brain. Res. 172 2006 97 105
22. G. Gheusi, H. Cremer, H. McLean, G. Chazal, J.D. Vincent, and P.M. Lledo Importance of newly generated neurons in the adult olfactory bulb for odor discrimination Proc. Natl. Acad. Sci. USA 97 2000 1823 1828
23. S. Parrish-Aungst, M.T. Shipley, F. Erdelyi, G. Szabo, and A.C. Puche Quantitative analysis of neuronal diversity in the mouse olfactory bulb J. Comp. Neurol. 501 2007 825 836
24. A.D. Kraft, J.M. Lee, D.A. Johnson, Y.W. Kan, and J.A. Johnson Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element J. Neurochem. 98 2006 1852 1865
25. A.F. Hubbs, S.A. Benkovic, D.B. Miller, J.P. O'Callaghan, L. Battelli, D. Schwegler-Berry, and Q. Ma Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2 Am. J. Pathol. 170 2007 2068 2076
26. P.C. Chen, M.R. Vargas, A.K. Pani, R.J. Smeyne, D.A. Johnson, Y.W. Kan, and J.A. Johnson Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte Proc. Natl. Acad. Sci. USA 106 2009 2933 2938
27. J.M. Wilson, K.S. Kalasinsky, A.I. Levey, C. Bergeron, G. Reiber, R.M. Anthony, G.A. Schmunk, K. Shannak, J.W. Haycock, and S.J. Kish Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat. Med 2 1996 699 703
28. P.A. Brennan, and E.B. Keverne Neural mechanisms of mammalian olfactory learning Prog. Neurobiol. 51 1997 457 481
29. H. Kaneda, K. Maeshima, N. Goto, T. Kobayakawa, S. Ayabe-Kanamura, and S. Saito Decline in taste and odor discrimination abilities with age, and relationship between gustation and olfaction Chem. Senses 25 2000 331 337
30. G.W. Ross, H. Petrovitch, R.D. Abbott, C.M. Tanner, J. Popper, K. Masaki, L. Launer, and L.R. White Association of olfactory dysfunction with risk for future Parkinson's disease Ann. Neurol. 63 2008 167 173
31. K.B. Burrows, and C.K. Meshul High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity Neuroscience 90 1999 833 850
32. S. Jayanthi, X. Deng, P.A. Noailles, B. Ladenheim, and J.L. Cadet Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades FASEB J 18 2004 238 251
33. N.M. Abraham, V. Egger, D.R. Shimshek, R. Renden, I. Fukunaga, R. Sprengel, P.H. Seeburg, M. Klugmann, T.W. Margrie, A.T. Schaefer, and T. Kuner Synaptic inhibition in the olfactory bulb accelerates odor discrimination in mice Neuron 65 2010 399 411
34. E. Enwere, T. Shingo, C. Gregg, H. Fujikawa, S. Ohta, and S. Weiss Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination J. Neurosci. 24 2004 8354 8365
35. T. Yamamoto, K. Yoh, A. Kobayashi, Y. Ishii, S. Kure, A. Koyama, T. Sakamoto, K. Sekizawa, H. Motohashi, and M. Yamamoto Identification of polymorphisms in the promoter region of the human NRF2 gene Biochem. Biophys. Res. Commun. 321 2004 72 79
36. X. Wang, D.J. Tomso, B.N. Chorley, H.Y. Cho, V.G. Cheung, S.R. Kleeberger, and D.A. Bell Identification of polymorphic antioxidant response elements in the human genome Hum. Mol. Genet. 16 2007 1188 1200